Logo image of COLL

COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:COLL - US19459J1043 - Common Stock

46.23 USD
+0.63 (+1.38%)
Last: 11/26/2025, 8:24:12 PM
46.23 USD
0 (0%)
After Hours: 11/26/2025, 8:24:12 PM
Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to COLL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 47.74. This target is 3.26% above the current price.
COLL was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about COLL.
In the previous month the buy percentage consensus was at a similar level.
COLL was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
COLL Historical Analyst RatingsCOLL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -107 -97 -87 -77 -67 -57 -47 -37 -27 -17 -7 5 10 15

Price Target & Forecast

Price Low Median Mean High 46.2344.4448.9647.7450.40 - -3.87% 5.91% 3.26% 9.02%
COLL Current Analyst RatingCOLL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-11-07 Truist Securities Maintains Buy -> Buy
2025-11-07 HC Wainwright & Co. Maintains Buy -> Buy
2025-10-28 Needham Reiterate Buy -> Buy
2025-05-09 Piper Sandler Reiterate Neutral -> Neutral
2025-04-09 Needham Reiterate Buy -> Buy
2025-03-24 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-04 Piper Sandler Maintains Neutral -> Neutral
2025-01-10 Needham Upgrade Hold -> Buy
2025-01-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-11 Piper Sandler Reiterate Neutral -> Neutral
2024-09-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-09 Needham Reiterate Hold
2024-08-09 Truist Securities Maintains Buy -> Buy
2024-08-09 Piper Sandler Reiterate Neutral -> Neutral
2024-07-30 Needham Reiterate Hold
2024-07-30 HC Wainwright & Co. Upgrade Neutral -> Buy
2024-06-07 Jefferies Upgrade Hold -> Buy
2024-05-10 Needham Downgrade Buy -> Hold
2024-05-10 Piper Sandler Downgrade Overweight -> Neutral
2024-04-11 Needham Reiterate Buy -> Buy
2024-02-26 Truist Securities Maintains Buy -> Buy
2024-02-23 Piper Sandler Reiterate Overweight -> Overweight
2024-02-02 Needham Reiterate Buy -> Buy
2024-01-04 Needham Maintains Buy -> Buy
2024-01-04 Truist Securities Maintains Buy -> Buy
2024-01-04 Jefferies Downgrade Buy -> Hold
2023-08-25 Needham Maintains Buy -> Buy
2023-08-04 Needham Reiterate Buy -> Buy
2023-08-04 HC Wainwright & Co. Reiterate Neutral
2023-05-30 Needham Reiterate Buy -> Buy

COLLEGIUM PHARMACEUTICAL INC / COLL FAQ

What is the average price target for COLLEGIUM PHARMACEUTICAL INC (COLL) stock?

11 analysts have analysed COLL and the average price target is 47.74 USD. This implies a price increase of 3.26% is expected in the next year compared to the current price of 46.23.


How do analysts rate COLLEGIUM PHARMACEUTICAL INC (COLL)?

The consensus rating for COLLEGIUM PHARMACEUTICAL INC (COLL) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.


Can you provide the analyst count for COLLEGIUM PHARMACEUTICAL INC stock?

The number of analysts covering COLLEGIUM PHARMACEUTICAL INC (COLL) is 11.